From Risk Profiles to Real-World Evidence – CMV Management in SOT, Presented by Kamada
In this episode of the ISHLT Voices podcast, hosted by Kamada, you’ll hear the following experts discuss different cytomegalovirus (CMV) prophylaxis approaches in high-risk lung transplant patients:
The discussion is focused on real-world, long-term follow-up data published in 2025 by UT Southwestern. The conversation explores clinical rationale and center practices, highlighting data showing improved survival outcomes in high-risk patients. This episode aims to translate emerging evidence into practical insights for transplant clinicians.
The content of this podcast was developed entirely by our industry partner, Kamada. It is not an official educational program of the ISHLT, and therefore is not eligible for CME under the ISHLT.
This episode was created for ISHLT Voices and sponsored by Kamada.
